Genetic Technologies
(NASDAQ:GENE)
$2.47
0.03[1.23%]
At close: Apr 18
$2.47
0[0.00%]
PreMarket: 5:27PM EDT
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
About Genetic Technologies Ltd.
Sector
Health Care
Industry
Life Sciences Tools & Services
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
GENE
HBIO

FAQ

Q

How do I buy Genetic Technologies (GENE) stock?

A

You can purchase shares of Genetic Technologies (NASDAQ: GENE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Genetic Technologies's (GENE) competitors?

Q

What is the target price for Genetic Technologies (GENE) stock?

A

The latest price target for Genetic Technologies (NASDAQ: GENE) was reported by Ladenburg Thalmann on Friday, November 16, 2012. The analyst firm set a price target for 0.00 expecting GENE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Genetic Technologies (GENE)?

A

The stock price for Genetic Technologies (NASDAQ: GENE) is $2.47 last updated April 18, 2024 at 5:27 PM EDT.

Q

Does Genetic Technologies (GENE) pay a dividend?

A

There are no upcoming dividends for Genetic Technologies.

Q

When is Genetic Technologies (NASDAQ:GENE) reporting earnings?

A

Genetic Technologies’s Q1 earnings are confirmed for Monday, May 13, 2024.

Q

Is Genetic Technologies (GENE) going to split?

A

There is no upcoming split for Genetic Technologies.

Q

What sector and industry does Genetic Technologies (GENE) operate in?

A

Genetic Technologies is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch